Skip to main content
. 2021 Jun 2;11:659313. doi: 10.3389/fonc.2021.659313

Table 1b.

Patients’ protein expression.

Feature Total Nun-progressor Progressor Value - p
chi-squared log-rank t-test/U-test
No. of patients 95 71 24
Vegf-A:
Negative 49 (51.6%) 37 12 0.858 0.837 /
Positive 46 (48.4%) 34 12
Glut1:
Negative 41 (43.2%) 35 6 0.039 0.039 /
Positive 54 (56.8%) 36 18
E-cadherin:
Negative 52 (54.7%) 40 12 0.590 0.487 /
Positive 43 (45.3%) 31 12
Cox-2
Negative 66 (69.5%) 48 18 0.496 0.547 /
Positive 29 (30.5%) 23 6
Tenascin-C:
Negative 50 (52.6%) 35 15 0.264 0.332 /
Positive 45 (47.4%) 36 9
Tigar:
Negative 30 (31.6%) 22 8 0.831 0.848 /
Positive 65 (68.4%) 49 16